Charite University, Berlin, Germany: Clinical Trials

1144 trials sponsored by Charite University, Berlin, Germany, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

596 completed, 267 unknown, 138 recruiting, 67 terminated. 436 Not applicable, 147 Phase 2, 79 Phase 3, 50 Phase 4, 29 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable436Completed 248, Unknown 91, Recruiting 48, Terminated 21, Active not recruiting 8, Not yet recruiting 7, Withdrawn 7, Enrolling by invitation 4, Suspended 2
Phase 2147Completed 64, Unknown 46, Terminated 21, Recruiting 6, Active not recruiting 3, Not yet recruiting 3, Withdrawn 3, Suspended 1
Phase 379Completed 36, Unknown 23, Terminated 13, Not yet recruiting 3, Recruiting 3, Withdrawn 1
Phase 450Completed 33, Unknown 11, Recruiting 3, Terminated 3
Phase 129Completed 15, Unknown 5, Recruiting 4, Active not recruiting 2, Not yet recruiting 1, Terminated 1, Withdrawn 1
Early Phase 12Completed 2

Follow this sponsor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options
Liver transplantation - Colorectal Neoplasms, Liver Neoplasms
Not applicableNot yet recruitingCharite University, Berlin, Germany2602027-04-012026-09-10
Stratification and Treatment in Early Psychosis Study -ASSIST
CBD 100 mg/mL Oral Solution, Placeb - Treatment Resistant Psychosis, Psychosis
Phase 3Not yet recruitingUniversity of Oxford2502027-01-012026-10-08
Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congenital Heart Disease Undergoing Surgical Repair
End-expiratory lung volume optimization maneuver with PEEP titration, Standard Care (in control arm) - Congenital Heart Disease, Cardiopulmonary Bypass
Phase 1 / Phase 2Not yet recruitingCharite University, Berlin, Germany802027-01-012026-10-15
CD19-B Cell Depletion in PAIS-ME/CFS Patients
Inebilizumab, Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID 19 Condition (PCC or Long COVID)
Phase 2Not yet recruitingCharite University, Berlin, Germany382026-12-012026-07-24
Microneedle-based ISF Sampling Technique
PELSA System - No Condition, Healthy Individuals
Not applicableNot yet recruitingAscilion AB1102026-11-012026-10-21
Stratification and Treatment in Early Psychosis Study - ENHANCE
CBD 100 mg/mL Oral Solution, Placebo - Psychosis, First Episode Psychosis
Phase 3RecruitingUniversity of Oxford2502026-10-052026-10-08
Surgical Treatment of Adjacent Segment Stenosis
Microsurgical Decompression with Extension of Fusion, Microsurgical Decompression Alone - Adjacent Segment Disease, Lumbar Spinal Stenosis
Not applicableNot yet recruitingCharite University, Berlin, Germany3382026-10-012026-06-22
Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)
No Intervention: Observational Cohort - HIV
Not yet recruitingErasmus Medical Center2002026-10-012026-07-09
Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients
FOLFIRI+cetuximab, Guardant360 ctDNA assay - Colorectal Cancer Metastatic
Phase 3Not yet recruitingCharite University, Berlin, Germany2672026-10-012026-07-29
AngioVac Aspiration Therapy Registry
Retrospective analysis of assigned treatment - Intracardiac Thrombus, Intracardiac Mass
Not yet recruitingCharite University, Berlin, Germany10002026-10-012026-10-20
Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
Rituximab (R), Eculizumab (Soliris®), Ravulizumab - NMOSD
Phase 4RecruitingMassachusetts General Hospital5402026-09-012026-09-24
Development of Context-Adapted Quality Indicators for Early Sepsis Care in Sub-Saharan Africa - A Modified Delphi Consensus Procedure
Sepsis
RecruitingCharite University, Berlin, Germany452026-09-012026-09-09
Therapy Adjustment and IndividuaLized Response With Biomarker Observation in ReaL-world Heart Failure
Chronic Heart Failure, Acute Decompensated Heart Failure
Not yet recruitingMaastricht University Medical Center6002026-09-012026-06-15
Validation Testing for Plasma Oxalate Levels in the Biochemical Laboratory at the Galilee Medical Center, in Collaboration With the Biochemistry Laboratory at CHARITE Hospital in Berlin, and Testing the Relationship Between Oxalate Levels and Vitamin C Levels in Plasma
This is an non-interventional study - Hyperoxaluria
Not yet recruitingWestern Galilee Hospital-Nahariya502026-08-012026-05-07
Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition
High-Fiber Diet, High-Fiber Diet and Short-Term Fasting - Melanoma (Skin Cancer)
Not applicableRecruitingCharite University, Berlin, Germany602026-07-282026-07-29
Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE)
Intracerebral Haemorrhage, Paediatric Stroke
Not yet recruitingCharite University, Berlin, Germany127502026-07-272026-07-09
Effects of Olfactory Stimuli in Virtual Reality Cue Exposure on Craving and Attentional Bias in Alcohol Use Disorder
VR-CE - Alcohol Use Disorder
Not applicableNot yet recruitingCharite University, Berlin, Germany602026-07-012026-06-25
Evaluation of an Exercise Intervention During Intensive Medical Treatment in Pediatric Oncology.
Partially-standardised, supervised, continuity-of-care exercise intervention - Pediatric Cancer Patients
Not applicableRecruitingUniversität Duisburg-Essen3462026-07-012026-09-11
Prospective MMA Embolization Registry
Middle Meningeal Artery Embolization - Chronic Subdural Hematomas
Not yet recruitingCharite University, Berlin, Germany1002026-07-012026-06-04
A-TANGO Phase 2 Study
Placebo, TAK-242, G-CSF (Filgrastim) - Acute-On-Chronic Liver Failure, Alcoholic Hepatitis
Phase 2RecruitingYaqrit Ltd782026-06-292026-09-21

Showing 20 of 1144. Sign in to see all of them.

Conditions studied

Stroke (42)  ·  Motor Activity (38)  ·  Depression (24)  ·  Multiple Sclerosis (24)  ·  Neoplasms (23)  ·  COVID-19 (21)  ·  Heart Failure (21)  ·  Mental Disorders (21)  ·  Alcoholism (19)  ·  Ischemic Stroke (19)  ·  Obesity (19)  ·  Depressive Disorder, Major (18)  ·  Delirium (17)  ·  Fatigue (17)  ·  Psychological Well-Being (17)

Interventions

Transcranial Direct Current Stimulation (27)  ·  Exercise (11)  ·  Therapeutics (9)  ·  Angptl4 protein, mouse (8)  ·  Cognitive Behavioral Therapy (7)  ·  Observation (7)  ·  Rituximab (7)  ·  Sodium Chloride (7)  ·  Deep Brain Stimulation (6)  ·  Standard of Care (6)  ·  Acupuncture Therapy (5)  ·  Hydrocortisone (5)  ·  Mycophenolic Acid (5)  ·  Radiotherapy (5)  ·  Blood Specimen Collection (4)

Countries

Germany (1023)  ·  Italy (42)  ·  Austria (37)  ·  Switzerland (36)  ·  Spain (30)  ·  France (28)  ·  Netherlands (25)  ·  United Kingdom (25)  ·  United States (21)  ·  Belgium (17)  ·  Czechia (14)  ·  Hungary (14)  ·  Poland (14)  ·  Sweden (14)  ·  Israel (13)

Top investigators

Claudia Spies, MD, Prof. (54)  ·  Andreas Michalsen, Prof. Dr. (19)  ·  Claudia Spies, MD Prof. (13)  ·  Stefan J Schaller, MD (10)  ·  Claudia M Witt, MD (8)  ·  Ulrich Keilholz, MD (8)  ·  Andreas Meisel, MD (7)  ·  Andreas Meisel, Prof. Dr. med. (7)  ·  Fernando Dimeo, MD (6)  ·  Friedemann Paul, MD (6)  ·  Joachim Sieper, MD (6)  ·  Marcus Maurer, MD (6)

Results publications

PMID 23987123, PMID 33406266, PMID 22056301, PMID 24476416, PMID 25511185, PMID 27992268, PMID 28031392, PMID 28275197, PMID 29431878, PMID 30828313, PMID 31929543, PMID 32080086, PMID 32098866, PMID 32212061, PMID 32702903, PMID 33275200, PMID 33280547, PMID 33434727, PMID 33906377, PMID 35904671, PMID 36001430, PMID 37212760, PMID 38378503, PMID 38801091, PMID 38871878, PMID 40620229, PMID 41787671, PMID 42340058, PMID 42669063, PMID 11056673, PMID 11254005, PMID 11319598, PMID 12500206, PMID 12518365, PMID 12540795, PMID 14603333, PMID 14752084, PMID 15014526, PMID 15119545, PMID 15158091, PMID 15195901, PMID 15257960, PMID 15520707, PMID 16514090, PMID 16618337, PMID 16782926, PMID 17213237, PMID 17558345, PMID 17944340, PMID 17960012

NIH funding

2009 (4), 2014 (4), 2017 (4), 2023 (4), 2025 (4), 2008 (2), 2015 (2), 1ZIAAG000958-12 (1), 2005 (1), 2016 (1), 2018 (1), U01AI151799 (1), UL1TR001082 (1)